The ICMRA collaborative hybrid inspection pilot (CHIP)
by Giuliana Miglierini Hybrid inspections emerged during the pandemic as a new way to approach the assessment of…
EMA, new features for the PRIority Medicines (PRIME) scheme
By Giuliana Miglierini Based on the review of results obtained in the first five years of implementation of…
The opportunity for repurposing of oncology medicines
by Giuliana Miglierini Rare cancers, which account for approx. 22% of new cases in Europe, represent an area…